NeoGenomics Inc (STU:NG9)
€ 12.6 -0.1 (-0.79%) Market Cap: 1.76 Bil Enterprise Value: 1.96 Bil PE Ratio: 0 PB Ratio: 1.97 GF Score: 76/100

Neogenomics Inc Investor Day Transcript

Apr 04, 2023 / 12:00PM GMT
Release Date Price: €15.2 (-3.18%)
Operator

Good morning, everyone, and thank you for joining us here at NeoGenomics for our 2023 Investor Day. It's great to see so many faces in the audience today and signed in online. We're looking forward to sharing some details about our mission, vision and strategic priorities with you today. You'll be hearing from 5 members from our executive leadership team, and we'll conclude the day with a Q&A session.

Before I turn it over to Chris Smith, our Chief Executive Officer, I want to highlight our safe harbor and non-GAAP financial measures disclosure. And before we kick it off, I would like to show a quick video of what it means to be a teammate here at NeoGenomics.

(presentation)

Christopher Michael Smith
NeoGenomics, Inc. - CEO & Director

Good morning. Listen, we thanks so much for being here. I'm Chris Smith, CEO of NEO. And I love that video. It was not meant to be a recruiting video for the folks in the room. But I do want to share with you that as we've kind of gone through a transformation, we'll talk a lot about that today. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot